Trial Profile
Randomized Controlled Trial of Home Therapy With Caffeine Citrate in Moderately Preterm Infants With Apnea of Prematurity
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 15 Feb 2023
Price :
$35
*
At a glance
- Drugs Caffeine (Primary) ; Caffeine (Primary)
- Indications Apnoea
- Focus Therapeutic Use
- Acronyms MoCHA
- 08 Feb 2023 Planned End Date changed from 1 Oct 2023 to 1 Mar 2023.
- 08 Feb 2023 Planned primary completion date changed from 1 Oct 2023 to 1 Mar 2023.
- 08 Feb 2023 Status changed from recruiting to active, no longer recruiting.